Digital Transformation in Pharmaceutical Regulatory Affairs: Strategies for Accelerating Global Market Authorization
International Journal of Research and Applied Innovations · 12.03.2025 · 8 (02)
DOI: 10.15662/ijrai.2025.0802015 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Research and Applied Innovations, online erschienen am 12.03.2025. Verfasst von Omer Wasiq.
Abstract (Originalsprache)
Digital solutions for pharmaceutical regulatory affairs are urgently needed, as existing routes still require cumbersome, lengthy submission processes based on slow paper-based formats, delaying approvals in multiple countries. Artificial intelligence and machine learning can automatically analyse, generate, and organise vast amounts of data for pharmaceutical applications. At the same time, cloud-based review platforms enable companies and regulatory agencies to share documents transparently and review them jointly. Structured data standards, building on and beyond the electronic common technical document, can help to improve clarity and facilitate review by machines as well as humans. These automation tools and new approaches facilitate strategies to accelerate the number of multi- country filings significantly, reduce response times to questions from authorities, and enable a more synchronised global market authorisation. Patients would benefit from earlier availability of innovative therapies, while industry can save significantly on time and cost impacts without compromising safety or quality. However, the industry faces several major barriers, such as the very different technical systems and requirements across disparate countries and regions, the need for better internal data infrastructures and trained staff, and the expectation for regulators to adapt and optimise their own working tools and principles proactively. The industry will need to work closely with health authorities to make digital approaches truly reliable and provide faster pathways for access to treatment.
Zitieren
APA
Wasiq, O. (2025). Digital Transformation in Pharmaceutical Regulatory Affairs: Strategies for Accelerating Global Market Authorization. International Journal of Research and Applied Innovations, 8(02). https://doi.org/10.15662/ijrai.2025.0802015
Vancouver
Wasiq O. Digital Transformation in Pharmaceutical Regulatory Affairs: Strategies for Accelerating Global Market Authorization. International Journal of Research and Applied Innovations. 2025;8(02). doi:10.15662/ijrai.2025.0802015
BibTeX
@article{Wasiq2025,
author = {Wasiq, Omer},
title = {Digital Transformation in Pharmaceutical Regulatory Affairs: Strategies for Accelerating Global Market Authorization},
journal = {International Journal of Research and Applied Innovations},
year = {2025},
volume = {8},
number = {02},
doi = {10.15662/ijrai.2025.0802015}
}
EUVIMED